• Wed news: 2025 Medicare drug price negotiations. BioAge Labs aiming at $180M IPO. Merck Keytruda colorectal cancer flop. Sanofi gets bids for consumer health unit. Novo Nordisk CEO in Senate hot seat. See more on our front page

Stock Price


<







So yes buying opportunity,idk?!? Thinking out loud here. If it's Too low then stock will prob go up, just not right now. If it doesn't go through then we bank a breakup fee of 3-4billion? Sounds like allergan is in a good spot regardless.

So buck up...sell your products and drive our share bc the better we sell the more 11.3 pfizer shares get us.

Ps Pfizer won't tolerate legacy forest, legacy Watson, legacy whatever bs. U work for the company that pays u.

watch the movie miracle. Team America. Or you will sprint again...
 








We've been in a global deflationary enviornment since the 2008 crash...central banks the world over have been attempting to counteract this with ZIRP, QE and MBS purchase programs.

Those efforts have run there course, racked up trillions in sovereign debt and are a major reason why we've seen so much M&A...cheap debt and corporations chasing returns.

The stock market is finally facing reality, as have many other economic indicators, and is responding to these pressures. The Fed is basically out of ammo and will not be able to stop the bleeding this time around.

IMO we are nowhere near a bottom and if you do buy now you will be catching a falling knife. Cash is king at this point in time.